[Skip to Content]

Upstate Active Clinical Trials

CategoryPrincipal InvestigatorKeyword OR
ClinicalTrials.Gov ID
 

You searched for Category (Rheumatology): 10 trials found.

Click sort in the column header to sort records.
Study TitlePI
A Master Protocol for a Randomized, Placebo-Controlled Clinical Trial of Multiple Interventions for the Treatment of Systemic Lupus Erythematosus. J1V-MC-IMMA
Read more
Andras Perl, MD, PhD
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Lupus Erythematosus. SL0043
Read more
Andras Perl, MD, PhD
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care. 230LE303
Read more
Andras Perl, MD, PhD
A Phase 1B, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosentuzumab to Participants with Systemic Lupus Erythemastosus. GA43191
Read more
Andras Perl, MD, PhD
A Randomized, Double Blind, Placebo controlled, dose assessment phase II study to evaluate the safety and efficacy of CCX168 in subjects with anti-neutrophil cytoplasmic antibody (ANCAAssociated Vasculitis)
Read more
Sriram S Narsipur
A two-year, phase III randomized, double-blind, parallel-group, placebo-controlled trial to evaluate the safety, efficacy, and tolerability of 300 mg s.c. secukinumab versus placebo, in combination with SoC therapy, in patients with active lupus nephritis. CAIN457Q12301
Read more
Andras Perl, MD, PhD
AMG 592 - A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects with Active Systemic Lupus Erythematosus with Inadequate Response to Standard of Care Therapy 20200234
Read more
Andras Perl, MD, PhD
Molecular Biology and Pathology of Transaldolase
Read more
Andras Perl, MD, PhD
ROLE of HTLVS and related endogenous sequences in autoimmune diseases and human cancers
Read more
Andras Perl, MD, PhD
Systemic Lupus Erythematosus (SLE) Treatment with N-acetylcysteine (NAC) (SNAC)
Read more
Andras Perl, MD, PhD

Search Again

Top